K938-1829 Screening compound: N-(3-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-1-(furan-2-yl)-3-oxopropyl)-4-methoxybenzene-1-sulfonamide

K938-1829 Screening compound: N-(3-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-1-(furan-2-yl)-3-oxopropyl)-4-methoxybenzene-1-sulfonamide
K938-1829 Screening compound: N-(3-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-1-(furan-2-yl)-3-oxopropyl)-4-methoxybenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K938-1829
N-(3-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-1-(furan-2-yl)-3-oxopropyl)-4-methoxybenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K938-1829

Molecular Formula

C21H26N2O7S (C21 H26 N2 O7 S)

Compound Name

N-(3-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-1-(furan-2-yl)-3-oxopropyl)-4-methoxybenzene-1-sulfonamide

IUPAC name

N-(3-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-1-(furan-2-yl)-3-oxopropyl)-4-methoxybenzene-1-sulfonamide

SMILES

COc(cc1)ccc1S(NC(CC(N(CC1)CCC11OCCO1)=O)c1ccco1)(=O)=O

InChI

InChI=1S/C21H26N2O7S/c1-27-16-4-6-17(7-5-16)31(25,26)22-18(19-3-2-12-28-19)15-20(24)23-10-8-21(9-11-23)29-13-14-30-21/h2-7,12,18,22H,8-11,13-15H2,1H3/t18-/m0/s1

InChI Key

SUQCWFMVCHJDGM-SFHVURJKSA-N

MDL Number (MFCD)

MFCD03020796

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

450.51

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.664

Distribution Coefficient, logD

1.664

Water Solubility, LogSw

-2.58

Polar Surface Area

88.520

Acid Dissociation Constant (pKa)

11.09

Base Dissociation Constant (pKb)

-0.88

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.60

K938-1829 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K938-1829 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K938-1829?
Check Price and Availability of K938-1829, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K938-1829 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K938-1829
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K938-1829
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K938-1829 available by request